Form4insider filings, from the source

SEC Form 4 · accession 0001225208-17-009781

Edwards Lifesciences Corp · EW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Huimin Wang
Officer — CVP, Japan & Intercontinental
Period of report
May 11, 2017
Accepted (ET)
May 15, 2017 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2May 11, 2017A1,500$0.00A80,991D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Acquire)F2,F3$110.25May 11, 2017A14,700AJun 11, 2017May 10, 2024Common Stock14,70014,700D
Performance RightsF4,F2—May 11, 2017A1,875AMay 11, 2020—Common Stock1,8751,875D

Explanation of responses